Roxane recalls two lots of hyperkalemia drug

COLUMBUS, Ohio Boehringer Ingelheim’s generic subsidiary has recalled two lots of a drug after finding them contaminated with yeast.

Roxane Laboratories found the lots of sodium polystyrene sulfonate contaminated with a type of yeast that can cause infections in patients with suppressed immune systems. The lots comprise about 100,000 bottles.

The drug is used to treat abnormally high potassium in the bloodstream, a disease called hyperkalemia. Sanofi-Aventis markets the drug as Kayexalate, while Paddock Laborabories markets it as Kionex.